Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas

Neurology India

Volumn 56, Issue 4, 2008, Pages 456-462

  Maiti, Arpan ^a   Ghosh, Keya ^a   Chatterjee, Uttara ^a   Chakrobarti, Sasanka ^a   Chatterjee, Sandip ^b   Basu, Samik ^c  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b Park Clinic   (India)

^c Bhagirathi Neotia Women and Child Care Centre   (India)

Author keywords

Astrocytoma; Epidermal growth factor receptor; Glioblastoma; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LABELING INDEX; MALE; PATHOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 58749085910     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.44827     Document Type: Article

References (37)

1. Lantos PL, VandenBerg SR, Kleihues P. Tumours of the nervous system. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Arnold; 1996. p. 583-879.
2. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992;52:674-9.
3. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-21.
4. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988;48:5546-51.
5. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 1987;84:6899-903.
6. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984;309:418-25.
7. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003;22:2361-73.
8. Nagane M, Coufal F, Lin H, Bögler O, Cavenee WK, Huang HJ. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 1996;56:5079-86.
9. Prigent SA, Nagane M, Lin H, Huvar I, Boss GR, Feramisco JR, et al. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem 1996;271:25639-45.
10. Torp SH, Helseth E, Dalen A, Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 1991;33:61-4.
11. Huncharek M, Kupelnick B. Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: Results of a meta-analysis. Oncol Res 2000;12:107-12.
12. Worm K, Dabbagh P, Schwechheimer K. Reverse transcriptase polymerase chain reaction as a reliable method to detect epidermal growth factor receptor exon 2-7 gene deletion in human glioblastomas. Hum Pathol 1999;30:222-7.
13. Pedersen PH, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR, Laerum OD. Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer 1994;56:255-61.
14. Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 1992;89:2965-9.
15. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994;91:7727-31.
16. Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993;4:121-33.
17. Feldkamp MM, Lala P, Lau N, Roncari L, Guha A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 1999;45:1442-53.
18. El-Obeid A, Bongcam-Rudloff E, Sörby M, Ostman A, Nistér M, Westermark B. Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. Cancer Res 1997;57:5598-604.
19. Nagane M, Lin H, Cavenee WK, Huang HJ. Expression of a specific mutant epidermal growth factor receptor mediates glioma cell invasion in vivo. Proc Am Assoc Cancer Res 1996;36:519-26.
20. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 1998;95:5724-9.
21. Bian XW, Shi JQ, Liu FX. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors. Anal Quant Cytol Histol 2000;22:429-37.
22. Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res 1996;56:3859-61.
23. Och W, Mariak Z, Smółka M, Badowski J, Koziorowski M. Epidermal growth factor expression in brain neoplasms. Neurol Neurochir Pol 2000;34:1165-72.
24. Ringertz N. Grading of gliomas. Acta Pathol Microbiol Scand 1950;27:51-64.
25. Hall PA, Coates PJ, Goodlad RA, Hart IR, lane DP. Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo. Br J Cancer 1994;70:244-7.
26. Masih PJ, Kunnev D, Melendy T. Mismatch Repair proteins are recruited to replicating DNA through interaction with Proliferating Cell Nuclear Antigen (PCNA). Nucleic Acids Res 2008;36:67-75.
27. Sallinen PK, Haapasalo HK, Visakorpi T, Helén PT, Rantala IS, Isola JJ, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994;174:275-82.
28. Allegranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta M, . Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch A Pathol Anat Histopathol 1991;419:417-23.
29. Scott RJ, Hall PA, Haldane JS, van Noorden S, Price Y, Lane DP, et al. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 1991;165:173-8.
30. van der Valk P, Lindeman J, Kamphorst W. Growth factor profiles of human gliomas: Do non-tumour cells contribute to tumour growth in glioma? Ann Oncol 1997;8:1023-9.
31. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001;93:1246-56.
32. Waha A, Baumann A, Wolf HK, Fimmers R, Neumann J, Kindermann D, et al. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. J Neurosurg 1996;85:634-41.
33. Bouvier-Labit C, Chinot O, Ochi C, Gambarelli D, Dufour H, Figarella-Branger D. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol 1998;24:381-8.
34. Yoshimura J, Onda K, Tanaka R, Takahashi H. Clinicopathological study of diffuse type brainstem gliomas: Analysis of 40 autopsy cases. Neurol Med Chir 2003;43:375-82.
35. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD. Effects of EGF, bFGF, NGF and PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 1993;53:209-14.
36. Sugawa N, Yamamoto K, Ueda S, Morita N, Kita M, Nishino H, et al. Function of aberrant EGFR in malignant gliomas. Brain Tumor Pathol 1998;15:53-7.
37. Mottolese M, Natali PG, Coli A, Bigotti G, Benevolo M, Cione A, et al. Comparative analysis of proliferating cell nuclear antigen and epidermal growth factor receptor expression in glial tumours: Correlation with histological grading. Anticancer Res 1998;18:1951-6.